8-K Announcements
6Material company update
May 18, 2026·SEC
Material company update
May 7, 2026·SEC
Material company update
May 1, 2026·SEC
Vericel Corporation(VCEL)Earnings, Financials & Key Ratios
VCEL•NASDAQ
125.3× P/E·Price updated Jun 19, 2026
AboutVericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.Show more
- Revenue$276M+16.5%
- EBITDA$22M+123.5%
- Net Income$17M+59.4%
- EPS (Diluted)0.32+60.0%
- Gross Margin74.42%+2.6%
- EBITDA Margin8.11%+92.0%
- Operating Margin4%+109.9%
- Net Margin5.98%+36.9%
- ROE5.11%+27.7%
VCEL Key Insights
Vericel Corporation (VCEL) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y profit CAGR of 42.0%
- ✓Strong Piotroski F-Score: 8/9
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 17.3%
✗Weaknesses
- ✗Weak 3Y average ROE of 2.5%
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when VCEL posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
VCEL Price & Volume
Vericel Corporation (VCEL) stock price & volume — 10-year historical chart
Loading chart...
VCEL Growth Metrics
Vericel Corporation (VCEL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years18.37%
5 Years17.34%
3 Years18.9%
TTM22.45%
Profit CAGR
10 Years-
5 Years41.97%
3 Years-
TTM620.69%
EPS CAGR
10 Years-
5 Years39.49%
3 Years-
TTM1077.4%
Return on Capital
10 Years-12.84%
5 Years-1.97%
3 Years0.54%
Last Year2.69%
VCEL Recent Earnings
Vericel Corporation (VCEL) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
May 7, 2026Metric
Actual
Est
EPS
$0.12+20.0%
$0.15
Rev
$68M+7.5%
$64M
Q1 2026
Feb 26, 2026Metric
Actual
Est
EPS
$0.45+0.0%
$0.45
Rev
$93M+2.1%
$91M
Q4 2025
Nov 6, 2025Metric
Actual
Est
EPS
$0.10+600.0%
$0.02
Rev
$68M-27.2%
$93M
Q3 2025
Jul 31, 2025Metric
Actual
Est
EPS
$0.01+75.0%
$0.04
Rev
$63M-2.1%
$65M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $0.12vs $0.15+20.0% | $68Mvs $64M+7.5% |
| Q1 2026 | Feb 26, 2026 | $0.45vs $0.45+0.0% | $93Mvs $91M+2.1% |
| Q4 2025 | Nov 6, 2025 | $0.10vs $0.02+600.0% | $68Mvs $93M-27.2% |
| Q3 2025 | Jul 31, 2025 | $0.01vs $0.04+75.0% | $63Mvs $65M-2.1% |
Based on last 12 quarters of dataView full earnings history →
VCEL Peer Comparison
Vericel Corporation (VCEL) competitors in Regenerative Medicine and Tissue Engineering — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 MGTX | 1.05B | 11.32 | -7.97 | 144.57% | -151.12% | -368.19% | ||
 RCKT | 365.8M | 3.35 | -1.67 | -70.79% | 0.09 | |||
 FATE | 243.61M | 2.09 | -1.82 | -51.24% | -20.57% | -58.89% | 0.38 | |
 AGIO | 2.03B | 34.16 | -4.80 | 48.03% | -6.4% | -34.11% | 0.05 | |
 NTLA | 1.76B | 15.67 | -4.11 | 16.92% | -5.97% | -57.27% | 0.14 | |
 SGMO | 74.57M | 0.18 | -0.41 | -31.57% | -356.89% | -28.92% | ||
 MDXG | 545.24M | 3.67 | 11.47 | 19.99% | 7.88% | 12.86% | 0.09 | |
 TELA | 36.85M | 0.82 | -0.99 | 15.84% | -49.3% | -13.44% | 8.82 |
Compare VCEL vs Peers
Vericel Corporation (VCEL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
VCEL Income Statement
Vericel Corporation (VCEL) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 63.92M | 90.86M | 117.85M | 124.18M | 156.18M | 164.37M | 197.52M | 237.22M | 276.26M | 292.09M |
Revenue Growth % | 17.54% | 42.13% | 29.71% | 5.37% | 25.77% | 5.24% | 20.17% | 20.1% | 16.45% | 22.45% |
Cost of Goods Sold | 30.35M | 32.16M | 37.57M | 39.95M | 50.16M | 54.58M | 61.94M | 65.12M | 70.66M | 73.49M |
COGS % of Revenue | 47.48% | 35.4% | 31.88% | 32.17% | 32.12% | 33.2% | 31.36% | 27.45% | 25.58% | - |
Gross Profit | 33.57M▲ 0% | 58.7M▲ 74.8% | 80.28M▲ 36.8% | 84.23M▲ 4.9% | 106.03M▲ 25.9% | 109.79M▲ 3.5% | 135.58M▲ 23.5% | 172.11M▲ 26.9% | 205.6M▲ 19.5% | 218.59M▲ 0% |
Gross Margin % | 52.52% | 64.6% | 68.12% | 67.83% | 67.88% | 66.8% | 68.64% | 72.55% | 74.42% | 74.84% |
Gross Profit Growth % | 28.74% | 74.85% | 36.77% | 4.92% | 25.88% | 3.55% | 23.49% | 26.95% | 19.46% | - |
Operating Expenses | 48.55M | 62.61M | 91.53M | 81.86M | 113.88M | 126.85M | 142.04M | 167.59M | 194.56M | 202.82M |
OpEx % of Revenue | 75.96% | 68.91% | 77.67% | 65.92% | 72.91% | 77.17% | 71.91% | 70.65% | 70.42% | - |
Selling, General & Admin | 35.61M | 49.01M | 61.14M | 68.84M | 97.59M | 106.9M | 121M | 142.79M | 166.99M | 174.41M |
SG&A % of Revenue | 55.71% | 53.94% | 51.88% | 55.43% | 62.49% | 65.04% | 61.26% | 60.19% | 60.45% | - |
Research & Development | 12.94M | 13.6M | 30.39M | 13.02M | 16.29M | 19.94M | 21.04M | 24.8M | 27.56M | 28.41M |
R&D % of Revenue | 20.25% | 14.97% | 25.79% | 10.48% | 10.43% | 12.13% | 10.65% | 10.45% | 9.98% | - |
Other Operating Expenses | -92K | -31K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -14.98M▲ 0% | -3.91M▲ 73.9% | -11.25M▼ 187.8% | 2.37M▲ 121.1% | -7.85M▼ 431.1% | -17.06M▼ 117.2% | -6.46M▲ 62.1% | 4.52M▲ 169.9% | 11.04M▲ 144.4% | 15.77M▲ 0% |
Operating Margin % | -23.44% | -4.3% | -9.55% | 1.91% | -5.03% | -10.38% | -3.27% | 1.91% | 4% | 5.4% |
Operating Income Growth % | 22.14% | 73.91% | -187.82% | 121.08% | -431.11% | -117.19% | 62.11% | 169.91% | 144.39% | - |
EBITDA | -13.37M | -2.48M | -9.51M | 4.75M | -4.89M | -13.08M | -1.83M | 10.02M | 22.41M | 28.07M |
EBITDA Margin % | -20.92% | -2.73% | -8.07% | 3.83% | -3.13% | -7.96% | -0.93% | 4.23% | 8.11% | 9.61% |
EBITDA Growth % | 22.97% | 81.43% | -282.88% | 150.02% | -202.82% | -167.48% | 85.99% | 647.11% | 123.54% | 601.35% |
D&A (Non-Cash Add-back) | 1.61M | 1.43M | 1.74M | 2.38M | 2.96M | 3.98M | 4.63M | 5.5M | 11.36M | 12.3M |
EBIT | -16.18M | -6.41M | -9.66M | 3.05M | -7.58M | -15.62M | -1.77M | 11.12M | 18.93M | 21.04M |
Net Interest Income | -1.09M | -835K | 1.61M | 685K | 220K | 975K | 4.03M | 5.8M | 5.45M | 6.56M |
Interest Income | 14K | 897K | 1.61M | 691K | 224K | 1.34M | 4.63M | 6.41M | 7.01M | 7.2M |
Interest Expense | 1.11M | 1.73M | 8K | 6K | 4K | 366K | 600K | 614K | 1.56M | 637K |
Other Income/Expense | -2.3M | -4.23M | 1.59M | 672K | 272K | 1.07M | 4.1M | 5.99M | 6.33M | 6.55M |
Pretax Income | -17.29M▲ 0% | -8.14M▲ 52.9% | -9.66M▼ 18.8% | 3.04M▲ 131.5% | -7.58M▼ 349.1% | -15.99M▼ 110.9% | -2.37M▲ 85.2% | 10.51M▲ 543.8% | 17.38M▲ 65.3% | 22.32M▲ 0% |
Pretax Margin % | -27.04% | -8.96% | -8.2% | 2.45% | -4.85% | -9.73% | -1.2% | 4.43% | 6.29% | 7.64% |
Income Tax | 0 | 0 | 0 | 180K | -111K | 721K | 814K | 148K | 859K | 859K |
Effective Tax Rate % | 0% | 0% | 0% | 5.91% | 1.46% | -4.51% | -34.38% | 1.41% | 4.94% | 3.85% |
Net Income | -17.29M▲ 0% | -8.14M▲ 52.9% | -9.66M▼ 18.8% | 2.86M▲ 129.6% | -7.47M▼ 360.9% | -16.71M▼ 123.7% | -3.18M▲ 81.0% | 10.36M▲ 425.6% | 16.52M▲ 59.4% | 21.46M▲ 0% |
Net Margin % | -27.04% | -8.96% | -8.2% | 2.31% | -4.78% | -10.17% | -1.61% | 4.37% | 5.98% | 7.35% |
Net Income Growth % | 11.65% | 52.93% | -18.78% | 129.63% | -360.86% | -123.65% | 80.96% | 425.64% | 59.41% | 620.69% |
Net Income (Continuing) | -17.29M | -8.14M | -9.66M | 2.86M | -7.47M | -16.71M | -3.18M | 10.36M | 16.52M | 21.46M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -0.52▲ 0% | -0.20▲ 61.5% | -0.18▲ 10.0% | 0.06▲ 133.7% | -0.16▼ 364.0% | -0.35▼ 118.7% | -0.07▲ 80.9% | 0.20▲ 399.0% | 0.32▲ 60.0% | 0.42▲ 0% |
EPS Growth % | 38.82% | 61.54% | 10% | 133.67% | -364.03% | -118.75% | 80.89% | 398.95% | 60% | 1077.4% |
EPS (Basic) | -0.52 | -0.20 | -0.18 | 0.06 | -0.16 | -0.35 | -0.07 | 0.21 | 0.33 | - |
Diluted Shares Outstanding | 33.35M | 40.24M | 44.18M | 47.28M | 46.47M | 47.13M | 47.59M | 51.68M | 52.07M | 50.77M |
Basic Shares Outstanding | 33.35M | 40.24M | 44.18M | 45.22M | 46.47M | 47.13M | 47.59M | 48.85M | 50.59M | 50.77M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
VCEL Balance Sheet
Vericel Corporation (VCEL) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 50.51M | 112.78M | 111.66M | 123.56M | 158.46M | 186.87M | 205.63M | 212.78M | 247.44M | 244.06M |
Cash & Short-Term Investments | 26.86M | 82.92M | 69.72M | 75.81M | 103.4M | 119.54M | 109.56M | 116.21M | 137.5M | 145.34M |
Cash Only | 26.86M | 18.29M | 26.89M | 33.62M | 68.33M | 51.07M | 69.09M | 74.52M | 100.09M | 109.3M |
Short-Term Investments | 0 | 64.64M | 42.83M | 42.19M | 35.07M | 68.47M | 40.47M | 41.69M | 37.41M | 36.05M |
Accounts Receivable | 18.27M | 23.45M | 32.17M | 34.5M | 37.44M | 46.54M | 58.36M | 61.38M | 84.63M | 72.38M |
Days Sales Outstanding | 104.32 | 94.22 | 99.63 | 101.42 | 87.49 | 103.35 | 107.84 | 94.43 | 111.82 | 88.02 |
Inventory | 3.79M | 3.56M | 6.82M | 9.36M | 13.38M | 15.99M | 13.09M | 17.37M | 17.56M | 18.35M |
Days Inventory Outstanding | 45.61 | 40.38 | 66.22 | 85.48 | 97.37 | 106.91 | 77.12 | 97.38 | 90.71 | 88.03 |
Other Current Assets | 1.58M | 2.85M | 2.95M | 3.89M | 4.25M | 4.8M | 24.63M | 17.82M | 7.74M | 7.99M |
Total Non-Current Assets | 4.07M | 5.91M | 41.58M | 82.05M | 85.24M | 86.14M | 148.03M | 219.94M | 240.53M | 241.56M |
Property, Plant & Equipment | 4.07M | 5.91M | 32.25M | 57.74M | 59.03M | 57.37M | 115.1M | 173.26M | 173.17M | 170.52M |
Fixed Asset Turnover | 15.70x | 15.38x | 3.65x | 2.15x | 2.65x | 2.86x | 1.72x | 1.37x | 1.60x | 1.68x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 7.5M | 6.88M | 6.25M | 5.63M | 5.47M |
Long-Term Investments | 0 | 0 | 9.25M | 24.1M | 25.69M | 19.96M | 25.28M | 39.88M | 61.4M | 223.74M |
Other Non-Current Assets | 0 | 0 | 89K | 211K | 528K | 1.3M | 771K | 556K | 341K | 288K |
Total Assets | 54.58M▲ 0% | 118.69M▲ 117.5% | 153.24M▲ 29.1% | 205.61M▲ 34.2% | 243.71M▲ 18.5% | 273M▲ 12.0% | 353.66M▲ 29.5% | 432.72M▲ 22.4% | 487.97M▲ 12.8% | 485.63M▲ 0% |
Asset Turnover | 1.17x | 0.77x | 0.77x | 0.60x | 0.64x | 0.60x | 0.56x | 0.55x | 0.57x | 0.63x |
Asset Growth % | 12.3% | 117.47% | 29.11% | 34.18% | 18.53% | 12.02% | 29.54% | 22.36% | 12.77% | 58.84% |
Total Current Liabilities | 13.09M | 14.79M | 19.8M | 22.48M | 26.05M | 37.46M | 45.75M | 50.29M | 49.15M | 47.16M |
Accounts Payable | 5.55M | 7.11M | 6.34M | 6.75M | 9.02M | 16.93M | 22.35M | 23.85M | 15.83M | 19.01M |
Days Payables Outstanding | 66.76 | 80.67 | 61.64 | 61.72 | 65.61 | 113.22 | 131.69 | 133.68 | 81.76 | 78.26 |
Short-Term Debt | 350K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14.09M | 14.06M |
Deferred Revenue (Current) | 5.99M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 4M | 7.47M | 6.9M | 9.2M | 9.92M | 10.27M | 13.26M | 13.7M | 19.24M | 14.08M |
Current Ratio | 3.86x | 7.62x | 5.64x | 5.50x | 6.08x | 4.99x | 4.49x | 4.23x | 5.03x | 5.18x |
Quick Ratio | 3.57x | 7.38x | 5.30x | 5.08x | 5.57x | 4.56x | 4.21x | 3.89x | 4.68x | 4.79x |
Cash Conversion Cycle | 83.17 | 53.93 | 104.21 | 125.18 | 119.25 | 97.03 | 53.27 | 58.14 | 120.77 | 97.78 |
Total Non-Current Liabilities | 18.95M | 1.67M | 22.35M | 48.87M | 47.19M | 43.27M | 81.96M | 90.47M | 84.18M | 82.24M |
Long-Term Debt | 16.89M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 80.36M |
Capital Lease Obligations | 0 | 0 | 22.35M | 48.87M | 47.19M | 43.27M | 81.86M | 89.59M | 84.18M | 254.35M |
Deferred Tax Liabilities | -27.87M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 2.06M | 1.67M | 0 | 0 | 0 | 0 | 100K | 876K | 0 | 1.88M |
Total Liabilities | 32.04M | 16.46M | 42.15M | 71.35M | 73.24M | 80.73M | 127.7M | 140.75M | 133.33M | 129.4M |
Total Debt | 17.24M | 0 | 27.85M | 53.3M | 50.18M | 47.57M | 88.04M | 98.85M | 98.27M | 94.42M |
Net Debt | -9.62M | -18.29M | 965K | 19.68M | -18.15M | -3.5M | 18.95M | 24.33M | -1.83M | -14.87M |
Debt / Equity | 0.76x | - | 0.25x | 0.40x | 0.29x | 0.25x | 0.39x | 0.34x | 0.28x | 0.27x |
Debt / EBITDA | - | - | - | 11.21x | - | - | - | 9.86x | 4.39x | 3.36x |
Net Debt / EBITDA | - | - | - | 4.14x | - | - | - | 2.43x | -0.08x | -0.53x |
Interest Coverage | -14.62x | -3.70x | -1207.13x | 508.33x | -1894.50x | -42.68x | -2.95x | 18.12x | 12.17x | 33.02x |
Total Equity | 22.54M▲ 0% | 102.23M▲ 353.6% | 111.09M▲ 8.7% | 134.26M▲ 20.9% | 170.46M▲ 27.0% | 192.27M▲ 12.8% | 225.95M▲ 17.5% | 291.97M▲ 29.2% | 354.64M▲ 21.5% | 356.23M▲ 0% |
Equity Growth % | -8.78% | 353.55% | 8.67% | 20.86% | 26.96% | 12.79% | 17.52% | 29.22% | 21.47% | 93.3% |
Book Value per Share | 0.68 | 2.54 | 2.51 | 2.84 | 3.67 | 4.08 | 4.75 | 5.65 | 6.81 | 7.02 |
Total Shareholders' Equity | 22.54M | 102.23M | 111.09M | 134.26M | 170.46M | 192.27M | 225.95M | 291.97M | 354.64M | 356.23M |
Common Stock | 383.02M | 471.18M | 489.75M | 510.06M | 553.9M | 593.25M | 629.23M | 684.78M | 730.66M | 739M |
Retained Earnings | -360.88M | -369.01M | -378.68M | -375.81M | -383.29M | -400M | -403.18M | -392.81M | -376.3M | -382.6M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -6.62M | -39K | 21K | 14K | -154K | -978K | -100K | 4K | 275K | -168K |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
VCEL Cash Flow Statement
Vericel Corporation (VCEL) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -13.18M | -412K | -7.18M | 17.57M | 29.04M | 17.69M | 35.31M | 58.16M | 51.91M | 61.69M |
Operating CF Margin % | -20.62% | -0.45% | -6.09% | 14.15% | 18.59% | 10.76% | 17.88% | 24.52% | 18.79% | - |
Operating CF Growth % | 33.73% | 96.87% | -1643.45% | 344.63% | 65.26% | -39.09% | 99.64% | 64.72% | -10.75% | 176.88% |
Net Income | -17.29M | -8.14M | -9.66M | 2.86M | -7.47M | -16.71M | -3.18M | 10.36M | 16.52M | 21.46M |
Depreciation & Amortization | 1.61M | 1.43M | 1.74M | 2.38M | 2.96M | 3.98M | 4.63M | 5.5M | 11.36M | 12.13M |
Stock-Based Compensation | 2.68M | 7.22M | 13.18M | 13.84M | 34.32M | 37.18M | 32.33M | 36.49M | 38.77M | 27.26M |
Deferred Taxes | 1.39M | 0 | -568K | 411K | 949K | 721K | 0 | 0 | 0 | 0 |
Other Non-Cash Items | -13K | 3.11M | 2.79M | 4.45M | 4.43M | 3.72M | 5.5M | 6.25M | 6.62M | 17.99M |
Working Capital Changes | -1.57M | -4.03M | -14.66M | -6.37M | -6.15M | -11.21M | -3.96M | -450K | -21.36M | -17.15M |
Change in Receivables | -1.18M | -5.18M | -8.71M | -2.34M | -2.93M | -9.1M | -11.82M | -3.02M | -23.26M | -19.48M |
Change in Inventory | -657K | 235K | -3.26M | -2.54M | -4.03M | -2.6M | 2.9M | -4.29M | -1.23M | -2.46M |
Change in Payables | -1.36M | 899K | -1.02M | 33K | 1.49M | 1.44M | 3.05M | -287K | 2.97M | 6.12M |
Cash from Investing | -1.51M | -67.03M | 10.62M | -17.16M | -3.5M | -36.21M | -3.13M | -79.03M | -43.94M | -33M |
Capital Expenditures | -1.51M | -2.68M | -2.62M | -2.63M | -7.92M | -7.6M | 0 | 0 | -27.16M | -3.89M |
CapEx % of Revenue | 2.36% | 2.95% | 2.22% | 2.11% | 5.07% | 4.62% | 13.93% | 26.97% | 9.83% | 1.33% |
Acquisitions | 0 | 2.68M | 2.62M | 2.63M | 7.92M | 7.6M | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | -1.51M | -2.68M | -2.62M | -2.63M | -7.92M | -7.6M | -27.51M | -63.97M | 0 | -10.32M |
Cash from Financing | 18.58M | 58.86M | 5.26M | 6.44M | 9.17M | 1.04M | 3.62M | 19.05M | 7.07M | 893K |
Debt Issued (Net) | 6.75M | -18.24M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Equity Issued (Net) | 8.22M | 70.03M | 5.29M | 6.63M | 11.18M | 3.65M | 6M | 24.52M | 13.93M | 6.09M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | 3.6M | 7.08M | -26K | -191K | -2.01M | -2.61M | -2.38M | -5.46M | -6.86M | -5.2M |
Net Change in Cash | 3.88M▲ 0% | -8.58M▼ 320.8% | 8.69M▲ 201.4% | 6.85M▼ 21.2% | 34.71M▲ 406.5% | -17.47M▼ 150.3% | 35.8M▲ 304.9% | -1.82M▼ 105.1% | 15.04M▲ 927.9% | 29.59M▲ 0% |
Free Cash Flow | -14.69M▲ 0% | -3.09M▲ 79.0% | -9.8M▼ 217.1% | 14.95M▲ 252.5% | 21.13M▲ 41.3% | 10.09M▼ 52.2% | 7.8M▼ 22.7% | -5.81M▼ 174.5% | 24.75M▲ 525.9% | 57.81M▲ 0% |
FCF Margin % | -22.99% | -3.4% | -8.31% | 12.04% | 13.53% | 6.14% | 3.95% | -2.45% | 8.96% | 19.79% |
FCF Growth % | 31.04% | 78.97% | -217.12% | 252.53% | 41.34% | -52.23% | -22.72% | -174.52% | 525.88% | 32.65% |
FCF per Share | -0.44 | -0.08 | -0.22 | 0.32 | 0.45 | 0.21 | 0.16 | -0.11 | 0.48 | 1.14 |
FCF Conversion (FCF/Net Income) | 0.76x | 0.05x | 0.74x | 6.14x | -3.89x | -1.06x | -11.10x | 5.61x | 3.14x | 2.69x |
Interest Paid | 931K | 0 | 8K | 6K | 4K | 0 | 383K | 399K | 0 | 0 |
Taxes Paid | 100K | 0 | 80K | 147K | 379K | 0 | 1.17M | 628K | 0 | 0 |
VCEL Key Ratios
Vericel Corporation (VCEL) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -73.17% | -13.04% | -9.06% | 2.33% | -4.9% | -9.21% | -1.52% | 4% | 5.11% | 6.41% |
Return on Invested Capital (ROIC) | -90.72% | -6.05% | -8.61% | 1.34% | -3.85% | -7.5% | -2.24% | 1.21% | 2.48% | 3.53% |
Gross Margin | 52.52% | 64.6% | 68.12% | 67.83% | 67.88% | 66.8% | 68.64% | 72.55% | 74.42% | 74.84% |
Net Margin | -27.04% | -8.96% | -8.2% | 2.31% | -4.78% | -10.17% | -1.61% | 4.37% | 5.98% | 7.35% |
Debt / Equity | 0.76x | - | 0.25x | 0.40x | 0.29x | 0.25x | 0.39x | 0.34x | 0.28x | 0.27x |
Interest Coverage | -14.62x | -3.70x | -1207.13x | 508.33x | -1894.50x | -42.68x | -2.95x | 18.12x | 12.17x | 33.02x |
FCF Conversion | 0.76x | 0.05x | 0.74x | 6.14x | -3.89x | -1.06x | -11.10x | 5.61x | 3.14x | 2.69x |
Revenue Growth | 17.54% | 42.13% | 29.71% | 5.37% | 25.77% | 5.24% | 20.17% | 20.1% | 16.45% | 22.45% |
Related:VCEL Dividend History·VCEL Revenue History·VCEL Price History·VCEL P/E History·VCEL Financial Ratios·VCEL Institutional Holders
VCEL SEC Filings & Documents
Vericel Corporation (VCEL) SEC filings — annual & quarterly reports (10-K, 10-Q)
VCEL Frequently Asked Questions
Vericel Corporation (VCEL) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Vericel Corporation (VCEL) reported $292.1M in revenue for fiscal year 2025. This represents a 18155% increase from $1.6M in 1996.
Vericel Corporation (VCEL) grew revenue by 16.5% over the past year. This is strong growth.
Yes, Vericel Corporation (VCEL) is profitable, generating $21.5M in net income for fiscal year 2025 (6.0% net margin).
Dividend & Returns
Vericel Corporation (VCEL) has a return on equity (ROE) of 5.1%. This is below average, suggesting room for improvement.
Vericel Corporation (VCEL) generated $57.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.